We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The guidance and forms you need to import a human medicine into the UK, including unlicensed medicines.
List of Field Safety Notices from 26 February to 1 March 2024
In 2006, BIS undertook a stock-take of regenerative medicine in the UK. This report provides an updated overview of the UK patent landscape.
Information from the National Health Service on conditions, treatments, local services and healthy living
Six new NHS trusts across England will receive funding for groundbreaking trial of artificial intelligence (AI) to diagnose prostate cancer quicker.
The Medicines and Healthcare products Regulatory Agency regulates medicines, medical devices and blood components for transfusion in the UK. MHRA is an executive agency, sponsored by the Department of Health and Social Care .
Guidance on what pharmacovigilance is and compliance issues from previous inspections.
Professional conduct panel outcome, including decision and reasons.
Summary List of field safety notices (FSNs) from medical device manufacturers from 11 to 15 July 2022.
Details of certificates issued under the Special Import System for the top ten veterinary medicines that were imported 1 Jan - 31 Mar 2024.
List of field safety notices (FSNs) from medical device manufacturers from 9 to 13 March 2015.
Directory of current ICH Guidelines which have been implemented by the Medicines and Healthcare products Regulatory Agency.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
medac GmbH (t/a medac Pharma LLP) is recalling the product for the batch specified in this notification due to particles detected during long-term stability tests.
A. Menarini Farmaceutica Internazionale Srl is recalling a specific batch as a precautionary measure due to the distribution of Invokana 300mg in Northern Ireland in packaging intended for the Greek market.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.